These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23645736)

  • 1. Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men.
    Sugie S; Mukai S; Tsukino H; Toda Y; Yamauchi T; Nishikata I; Kuroda Y; Morishita K; Kamoto T
    Anticancer Res; 2013 May; 33(5):1893-7. PubMed ID: 23645736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.
    Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
    Cancer Genomics Proteomics; 2015; 12(6):391-6. PubMed ID: 26543085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.
    Sagara Y; Mimori K; Yoshinaga K; Tanaka F; Nishida K; Ohno S; Inoue H; Mori M
    Br J Cancer; 2004 Aug; 91(5):959-65. PubMed ID: 15305200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin delays castration‑resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin‑1.
    Gao Y; Li L; Li T; Ma L; Yuan M; Sun W; Cheng HL; Niu L; Du Z; Quan Z; Fan Y; Fan J; Luo C; Wu X
    Int J Oncol; 2019 Jun; 54(6):2054-2068. PubMed ID: 31081050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N; Jørgensen PE; Sørensen BS; Nexø E
    Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of endothelial factors in prostate cancer: a possible role of caveolin-1 for tumour progression.
    Steiner I; Jung K; Miller K; Stephan C; Erbersdobler A
    Oncol Rep; 2012 Feb; 27(2):389-95. PubMed ID: 22075971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
    Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.
    Das K; Lorena PD; Ng LK; Lim D; Shen L; Siow WY; Teh M; Reichardt JK; Salto-Tellez M
    Endocr Relat Cancer; 2010 Sep; 17(3):757-70. PubMed ID: 20519274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancer.
    Chang WS; Lin SS; Li FJ; Tsai CW; Li LY; Lien CS; Liao WL; Wu HC; Tsai CH; Shih TC; Bau DT
    Anticancer Res; 2013 Nov; 33(11):4907-12. PubMed ID: 24222128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression screening of cancer/testis genes in prostate cancer identifies NR6A1 as a novel marker of disease progression and aggressiveness.
    Mathieu R; Evrard B; Fromont G; Rioux-Leclercq N; Godet J; Cathelineau X; Guillé F; Primig M; Chalmel F
    Prostate; 2013 Jul; 73(10):1103-14. PubMed ID: 23532770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
    Tahir SA; Frolov A; Hayes TG; Mims MP; Miles BJ; Lerner SP; Wheeler TM; Ayala G; Thompson TC; Kadmon D
    Clin Cancer Res; 2006 Aug; 12(16):4872-5. PubMed ID: 16914574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
    Satoh T; Yang G; Egawa S; Addai J; Frolov A; Kuwao S; Timme TL; Baba S; Thompson TC
    Cancer; 2003 Mar; 97(5):1225-33. PubMed ID: 12599229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
    Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant association of caveolin-1 (CAV1) genotypes with prostate cancer susceptibility in Taiwan.
    Wu HC; Chang CH; Tsou YA; Tsai CW; Lin CC; Bau DT
    Anticancer Res; 2011 Feb; 31(2):745-9. PubMed ID: 21378366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
    Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
    Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.
    Ishibashi Y; Tobisawa Y; Hatakeyama S; Ohashi T; Tanaka M; Narita S; Koie T; Habuchi T; Nishimura S; Ohyama C; Yoneyama T
    Prostate; 2014 Nov; 74(15):1521-9. PubMed ID: 25154914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of caveolin is associated with prostate and breast cancer.
    Yang G; Truong LD; Timme TL; Ren C; Wheeler TM; Park SH; Nasu Y; Bangma CH; Kattan MW; Scardino PT; Thompson TC
    Clin Cancer Res; 1998 Aug; 4(8):1873-80. PubMed ID: 9717814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.